Market Overview

Mid-Day Market Update: Dipexium Surges On Merger News; Bonanza Creek Energy Shares Decline


Midway through trading Friday, the Dow traded down 0.03 percent to 19,912.46 while the NASDAQ fell 0.02 percent to 5,446.40. The S&P also fell, dropping 0.01 percent to 2,260.81.

Leading and Lagging Sectors

Non-cyclical consumer goods & services shares gained around 0.53 percent in trading on Friday.

In trading on Friday, technology shares slipped by 0.17 percent. Meanwhile, top losers in the sector included Glu Mobile Inc. (NASDAQ: GLUU), down 2 percent, and Synaptics, Incorporated (NASDAQ: SYNA), down 2 percent.

Top Headline

Cal-Maine Foods Inc (NASDAQ: CALM) posted in-line loss for its second quarter, but sales missed expectations.

Cal-Maine Foods reported a Q2 loss of $0.48 per share on revenue of $253.5 million. Analysts were expecting a loss of $0.48 per share on revenue of $262.8 million.

Equities Trading UP

Dipexium Pharmaceuticals Inc (NASDAQ: DPRX) shares shot up 31 percent to $2.10 after the company announced plans to merge with privately-held PLx Pharma Inc in an all-stock deal.

Shares of Neothetics Inc (NASDAQ: NEOT) got a boost, shooting up 14 percent to $1.10 after the company reported the initiation of Phase 2 proof-of-concept trial for LIPO-202 for the reduction of submental subcutaneous fat.

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) shares were also up, gaining 7 percent to $5.06 after the company announced after Thursday's closing bell that its drug plecanatide, a daily pill to fight irritable bowel syndrome, had achieved positive top-line results from the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of the drug.

Equities Trading DOWN

Bonanza Creek Energy Inc (NYSE: BCEI) shares dropped 58 percent to $0.825 after the company reported that it has entered into a restructuring support agreement with bondholders holding more than $400 million in unsecured debt. The company also disclosed that it will commence its prepackaged bankruptcy case on or before January 5, 2017.

Shares of Cintas Corporation (NASDAQ: CTAS) were down around 5 percent to $114.81. Cintas reported weak earnings for its second quarter. However, the company raised its forecast for fiscal 2017.

Strongbridge Biopharma plc (NASDAQ: SBBP) was down, falling around 17 percent to $2.99. Strongbridge reported a Q2 loss of $0.36 per share and announced the acquisition of U.S. rights to KEVEYIS from Taro Pharmaceutical Industries. The company also announced a $35 million equity financing.


In commodity news, oil traded down 0.19 percent to $52.85 while gold traded up 0.35 percent to $1,134.70.

Silver traded down 0.42 percent Friday to $15.81, while copper fell 0.54 percent to $2.49.


European shares were mixed today. The eurozone’s STOXX 600 slipped 0.04 percent, the Spanish Ibex Index rose 0.17 percent, while Italy’s FTSE MIB Index climbed 0.84 percent. Meanwhile the German DAX fell 0.14 percent, and the French CAC 40 declined 0.05 percent while U.K. shares rose 0.06 percent.


New-home sales surged 5.2 percent to an annual rate of 592,000 in November. However, economists were expecting a 2.1 percent growth.

The University of Michigan's consumer sentiment index rose to 98.20 in December, versus a prior reading of 98.00. Economists were expecting a reading of 98.00.

The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

Posted-In: Earnings M&A News Eurozone Commodities Global Intraday Update Markets


Related Articles (CALM + BCEI)

View Comments and Join the Discussion!

How Much Capital Does A Trader Need?

Attention Investors: Here Is What You Need To Know About Last-Minute Shoppers